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Malignant melanoma is predomi-nantly a skin disease but in rare instances it may occur at other sites, 
including the mucous membrane of vulva, vagina, 
lips, throat, oesophagus, or perianal region, as well 
as the eye (uvea or retina). Malignant melanoma of 
the vagina is a rare entity, first reported by Poronas 
in 1887.1 It accounts for 2.6–2.8% of all primary 
malignant tumors of the vagina and 0.4–0.8 % of all 
malignant melanomas in females.2 Being of black 
race is considered as an adverse prognostic factor 
for   melanoma; however, the relative risk in white 
and black women was found to be equal.3
Vaginal melanoma is a highly malignant disease 
due to extensive lymphatic invasion. Additionally, 
its propensity for haematogenous spread due to 
early metastases is very common;2 hence, it is 
associated with a worse prognosis. Regardless of 
the therapy chosen, results of treatment have been 
poor, with reported five-year survival rates ranging 
from 10–20%.4,5
We report the case of a malignant melanoma 
having an uncommon morphology arising at the 
vaginal introitus. The morphological details and 
salient features of the case are discussed.
Case Report
A 66-year-old postmenopausal female presented 
to the outpatient department with complaints of a 
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سرطان اخللية املهبلية املدّورة امليالنيين اخلبيث
حالة نادرة
نينا ت�صوهان، د�صينت جور، ويد باثاك
امللخ�ض: ي�صاب اجللد غالبا بال�رصطان امليالنيني اخلبيث، ولكن يف حاالت نادرة قد ي�صيب هذا ال�رصطان اأن�صجة اأخرى. وُيعد �رصطان 
يَمُة  امليالنني يف املهبل حالة نادرة، كما اأّن نوع اخلاليا املدّورة غري ماألوف. على الرغم من ت�صخي�ض هذه احلالة �رصيريا بو�صفها حُلَ
املدّورة  املهبلية  اخللية  اأنها �رصطان  املناعي على  ال�صبغ  املناعية وفح�ض  ّية  امَلَر�صِ االأن�صجة  بوا�صطة فح�ض  �ُصخ�صت  لكنها  اإِْحليِليَّة، 
امل�صبوغة امليالنيني اخلبيث. رف�صت املري�صة اإجراء عملية جراحية جذرية واأعطيت دورة كاملة من العالج االإ�صعاعي لكنها توفيت بعد 
ذلك بعام. يكون ماآل �رصطان امليالنني املهبلي اخلبيث �صيئا للغاية حتى عندما تكون االآفة مو�صعية حني اكت�صافها، ويرتاوح معدل البقاء 
على قيد احلياة ملدة خم�ض �صنوات بني %20-10 ، ويتاأثر املاآل ح�صب حجم الورم، حيث يكون اأكرث �صوءا عندما يكون حجم الورم ≥3سم. 
وال يتاأثر معدل البقاء بالعمر وعدد اخلاليا ومرحلة ومكان االآفة.
مفتاح الكلمات: ميالنوما، مهبل، خباثة، �صبغة ما�صون فونتانا، �صبغة مناعية ن�صيجية كيميائية، اأورام خلية مدورة، تقرير حالة، الهند.
abstract: Malignant melanoma is predominantly a skin disease but in rare instances it may occur at other sites. 
A vaginal melanoma is a rare clinical entity and the round cell type is an uncommon variant. Although the present 
case was clinically diagnosed as a urethral caruncle, on histopathological examination and immunostaining it was 
diagnosed as a round cell pigmented malignant melanoma. The patient refused radical surgery and was given a full 
course radiotherapy treatment but died a year later. Malignant vaginal melanoma carries a very poor prognosis 
even when lesion is localised at the time of presentation. The five-year survival rate ranges from 10–20% with the 
prognosis being influenced by tumour size. A tumour size ≥3cm has a poor prognosis. Age, mitotic count, stage, 
and location of the lesion do not influence survival rates.
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growth near the vaginal introitus and blood-stained 
discharge per vaginum for the previous 2 months. 
There were no urinary symptoms. A vaginal 
hysterectomy had been performed 6 years before 
for a third degree uterovaginal prolapse. On general 
examination, the vital signs were within normal 
limits and a systemic examination did not reveal 
any significant abnormal findings.
On local examination, a dark brown nodular 
swelling measuring 30 x 25 mm was noted in 
between the urethra and the vaginal introitus. The 
surface of the tumour was ulcerated and bled on 
touch. On cystoscopic examination, the bladder 
was normal but the posterior wall of the urethra 
was stretched; however, no ulceration was seen. 
On per speculum examination, the anterior vaginal 
wall showed hyperpigmentation. On the basis of a 
clinical examination, the provisional diagnosis was 
an urethral caruncle. An excision biopsy showed a 
firm, greyish-brown soft tissue piece measuring 30 
x 25 x 15 mm. The cut surface showed dark brown 
areas towards the periphery. The depth of tumour 
invasion was >20 mm. Microscopic examination 
revealed an infiltrative cellular malignant tumour 
showing a diffuse pattern. The tumour cells were 
small and round with a small amount of pinkish 
cytoplasm, and rounded rather than uniform nuclei. 
Many nuclei showed prominent and large nucleoli. 
Mitotic figures were frequent. Occasionally, the 
cells and nuclei were oval and spindle shaped. A 
few multinucleate cells were also seen. In many 
places, the cells contained dark brown melanin 
pigment in the cytoplasm, which was confirmed 
histochemically by a Fontana-Masson ammoniated-
silver nitrate stain. The tumour cells were positive for 
S100 and HMB-45 immunostaining. The overlying 
mucosa was ulcerated and infiltrated by tumour 
cells. Lymphovascular invasion was also seen. A 
diagnosis of malignant melanoma was made. 
The patient refused radical surgical treatment; 
hence, radiotherapy was advised. The patient 
was referred to a radiotherapy centre where she 
received a full course of treatment. She lived for 
about one year but then died suddenly at home with 
complaints of sudden abdominal pain, possibly a 
complication of widespread metastatic disease.
Discussion
The present case is the first vaginal melanoma 
detected at our institution in 10 years. During this 
period, 6,080 malignancies were reported out of 
which 15 (0.24%) were malignant melanomas. In 
a comparative review constituting 84,836 cases of 
malignant melanomas occurring between 1985 
and 1994 from the National Cancer Data Base at 
Memorial Sloan Kettering Cancer Hospital Centre 
in New York, 91.2% were cutaneous, 5.2% were 
ocular, and 1.3% were mucosal malignancies, while 
2.2% had unknown primaries. It also revealed that 
in women, only 1.6% of melanomas were genital 
and only 21% of these, involved the vagina. The 
common presenting symptoms in 35 women treated 
for vaginal melanomas were vaginal bleeding in 
Figure 1: A photomicrograph showing ulcerated 
hyperplastic squamous epithelium (A). The deeper 
tissue shows a very infiltrative cellular tumour (B) 
with a diffuse pattern and a few clusters in some places 
(haematoxylin & eosin stain × 100).
Figure 2: A photomicrograph showing tumour cells 
which are mostly tiny with a small amount of cytoplasm 
and rounded nuclei with a prominent nucleolus. 
The inset shows tumour cells containing dark brown 
pigment in the cytoplasm (A) (haematoxylin & eosin 
stain × 400; Inset × 200).
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23 patients (66%), and pain in 1 patient (3%); the 
remaining 11 patients (31%) had no symptoms, 
with the disease being discovered during routine 
screening examinations.4
Our patient complained of a mass at the vaginal 
introitus and blood-stained discharge. The tumour 
was dark brown and ulcerated at the surface. As 
mentioned above, it was clinically misdiagnosed 
as an urethral caruncle.6 Also, because of the 
epithelial ulceration, it may have been mistaken 
for a squamous cell carcinoma.1 Although it was 
predominantly a small round cell tumour having 
a diffuse arrangement, the diagnosis was not a 
problem because of the presence of melanin pigment 
in the cytoplasm of the tumour cells. However, 
Scambia G. et al. reported that 6% of vaginal 
melanomas were amelanotic.7 If this small round 
cell melanoma had been amelanotic, the differential 
diagnosis could have included lymphoma, 
peripheral neuroectodermal tumour (PNET), 
Merkel cell tumour, and rhabdomyosarcoma.7 
Amelanotic melanomas would require the help of 
immunohistochemical stains such as S100, HMB-
45, vimentin, cytokeratin, leucocyte common 
antigen (LCA) and neuron-specific enolase (NSE) 
for diagnosis and to exclude other tumours. If 
the amelanotic melanoma had been a spindle-cell 
type then it would have had to be differentiated 
from malignant fibrohistiocytoma (MFH), a 
malignant peripheral nerve sheath tumour, and 
hemangiosarcoma.8 Other differential diagnoses 
which could have been considered were metastatic 
deposits of poorly differentiated malignancy, 
vaginal hemangioma, or endometriosis.
Malignant vaginal melanoma carries a very poor 
prognosis even when the lesion is localised at the 
time of presentation. The five-year survival rate 
ranges from 10–20%, with prognosis influenced by 
tumour size. A tumour measuring ≥3 cm has a poor 
prognosis. Patient age, mitotic count, tumour stage, 
and lesion location do not influence survival.9
The disease is associated with a high risk of 
local recurrence, distant metastasis, and poor 
clinical outcome. A retrospective review of 37 
cases of vaginal melanoma showed a survival rate 
of 19.1 months for Stage I disease. Other studies 
revealed that tumour size and nodal status were 
significant prognostic factors, whereas, tumour 
thickness was a weak predictor of survival. Several 
Figure 3: A photomicrograph showing melanin pigment 
in tumour cells (A). (Fontana-Masson silver stain × 200).
Figure 4: (A) Photomicrograph showing tumour cells’ positivity for S-100 protein (polyclonal anti-S-100 
immunostain using 3-Amino-9-Ethyl-l-Carbazole [AEC] chromogen, counterstain with Harris haematoxylin x 400). 
(B) Photomicrograph showing tumor cells positive for HMB-45. (HMB-45 antibody using 3,3'-Diaminobenzidine [DAB] 
chromogen, counter stain with Harris haematoxylin stain x 400). 
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types of treatment can be administered but none 
of them is considered a standard approach. There 
is no difference in survival between patients who 
have radical surgical procedures and those who 
have more conservative surgical procedures. 
Immunotherapy with interferon-alpha (IFN-alpha) 
has been demonstrated to reduce recurrence rates 
and offers a better chance of survival.10
Treatment modalities include surgical removal/
extirpation, irradiation, and chemotherapy either 
singly or in combination with other treatments. 
In the present case, excision was done. Wide local 
excision with pelvic node dissection was advised but 
the patient refused this surgery; hence, radiotherapy 
was advised. Follow-up treatment was not available 
at our institution. 
Conclusion
Vaginal melanoma is a rare clinical entity and the 
round cell type is an uncommon variant. Although 
the present case was clinically diagnosed as an 
urethral caruncle, histologically it was diagnosed 
as a round cell pigmented malignant melanoma. 
Immunostaining assisted in confirming the 
diagnosis.
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